The role of memory B cell in tonsil and peripheral blood in the clinical progression of IgA nephropathy

Human Immunology

Volumn 74, Issue 6, 2013, Pages 708-712

  Wu, Gang ^a,b   Peng, You Ming ^a   Liu, Fu You ^a   Xu, Daoliang ^b   Liu, Changhua ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; CHRONIC TONSILLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; TONSIL; TONSILLECTOMY;

ADULT; B-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PALATINE TONSIL; PHENOTYPE; PROTEINURIA; TONSILLECTOMY; YOUNG ADULT;

EID: 84877080676     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.028     Document Type: Article

References (30)

1. Strippoli G.F., et al. IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice. Am J Kidney Dis 2009, 53(1):5-8.
2. Barratt J., Feehally J. IgA nephropathy. J Am Soc Nephrol 2005, 16(7):2088-2097.
3. Alamartine E., et al. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991, 18(1):12-19.
4. Frimat L., et al. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des nephrologues de l'Est. Nephrol Dial Transplant 1997, 12(12):2569-2575.
5. Radford M.G., et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997, 8(2):199-207.
6. Koyama A., Igarashi M., Kobayashi M. Natural history and risk factors for immunoglobulin a nephropathy in Japan. Research group on progressive renal diseases. Am J Kidney Dis 1997, 29(4):526-532.
7. Feehally J. Predicting prognosis in IgA nephropathy. Am J Kidney Dis 2001, 38(4):881-883.
8. Alamartine E., et al. The use of the Oxford classification of IgA nephropathy to predict renal survival. Clin J Am Soc Nephrol 2011, 6(10):2384-2388.
9. Walsh M., et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Clin J Am Soc Nephrol 2010, 5(3):425-430.
10. Lundberg, S. et al. FGF23, Albuminuria, and Disease Progression in Patients with Chronic IgA Nephropathy. 2012.
11. Appel G.B., Waldman M. The IgA nephropathy treatment dilemma. Kidney Int 2006, 69(11):1939-1944.
12. Nishi H., et al. Effect and therapeutic mechanisms of tonsillectomy for childhood IgA nephropathy. Nephrology (Carlton) 2012, 17(7):658-664.
13. Ochi A., et al. Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol 2012, 10.1007/s11255-012-0251-8.
14. Suzuki Y., et al. Pathological role of tonsillar B cells in IgA nephropathy. Clin Dev Immunol 2011, 2011:639074.
15. Agematsu K., et al. CD27: a memory B-cell marker. Immunol Today 2000, 21(5):204-206.
16. Mansson A., et al. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 2006, 118(4):539-548.
17. Eaton-Bassiri A., et al. Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun 2004, 72(12):7202-7211.
18. Tangye S.G., et al. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998, 188(9):1691-1703.
19. Paramithiotis E., Cooper M.D. Memory B lymphocytes migrate to bone marrow in humans. Proc Natl Acad Sci U S A 1997, 94(1):208-212.
20. van den Wall Bake A.W., et al. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 1988, 72(2):321-325.
21. Suzuki K., et al. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003, 63(6):2286-2294.
22. Suzuki S., et al. Synthesis of immunoglobulins against Haemophilus parainfluenzae by tonsillar lymphocytes from patients with IgA nephropathy. Nephrol Dial Transplant 2000, 15(5):619-624.
23. Suzuki Y., Tomino Y. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. Semin Nephrol 2008, 28(1):66-77.
24. Suzuki Y., et al. Reevaluation of the mucosa-bone marrow axis in IgA nephropathy with animal models. Adv Otorhinolaryngol 2011, 72:64-67.
25. Suzuki Y., Tomino Y. The mucosa-bone-marrow axis in IgA nephropathy. Contrib Nephrol 2007, 157:70-79.
26. Rasmussen T., et al. In multiple myeloma clonotypic CD38-/CD19+/CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. Leuk Lymphoma 2004, 45(7):1413-1417.
27. Roodnat J.I., et al. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy. Nephrol Dial Transplant 1999, 14(2):353-359.
28. Coppo R. Can a dysregulated mucosal immune system in IgA nephropathy be controlled by tonsillectomy?. Nephrol Dial Transplant 2010, 25(8):2395-2397.
29. Locatelli F., Vecchio L.D., Pozzi C. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors. Nat Clin Pract Nephrol 2006, 2(1):24-31.
30. Kawamura T. Treatment of IgA nephropathy: corticosteroids, tonsillectomy, and mycophenolate mofetil. Contrib Nephrol 2007, 157:37-43.